Nanjing Well Pharmaceutical Group Co.,Ltd.

¥26.98As of Sun 8 Nov 2026, 12:00 UTC
SSE:603351Healthcare
Country China
PE (Fwd) •••
TSR 8Y CAGR 0.71%
Div yield 2.22%
ROE 8.62%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.47
PE TTM 23.26
TSR TTM (4.50%)
Mkt cap ¥3.654B
ROIC 8.18%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥34
27.14%
(84.65%)
Hold 6|12|6|11|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.30
0.31
0.34
0.38
8.58%
20.15%
34.64%
37.68%
Revenue¥M
335.5
348.8
360.7
376.4
14.46%
13.58%
12.09%
15.32%
Peers (US$547.8M)
Cap (US$)
PE
548.8M
19.00x
552.2M
149.0x
Capital
TTM
5Y
10Y
Leveragex
0.398
—
—
EBIT/Intx
0.557
0.125
0.139
Own earn%
(79.95)
(57.39)
(48.17)
Sh yield%
35.87
35.47
33.42
Owners
Insiders/Inst%
9.61
23.89
Short interest%
2.55
SBC / revenue%
1.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
3–9
$1 testx
—
Incr. ROIC%
24